A Washington State seafood company is recalling its caviar after the Canadian Food Inspection Agency tested and found the product was low in salt concentration. The issue was stated as potential Clostridium botulinum potential.
Article Citation:
A. H. W. HAUSCHILD and R. HILSHEIMER (1979) Effect of Salt Content and pH on Toxigenesis by Clostridium botulinum in Caviar. Journal of Food Protection: March 1979, Vol. 42, No. 3, pp. 245-248. https://doi.org/10.4315/0362-028X-42.3.245
Effect of Salt Content and pH on Toxigenesis by Clostridium botulinum in Caviar
A. H. W. HAUSCHILD* and R. HILSHEIMER
Bureau of Microbial Hazards, Health Protection Branch, Tunney's Pasture, Ottawa, Ontario, Canada K1A 0L2
Bottled lumpfish caviar was prepared with different salt (NaCl) concentrations and pH, and injected with spores of Clostridium botulinum. Under abusive storage conditions (30 C), outgrowth and toxigenesis occurred at combinations of ≤ 3.95% salt in the water phase and pH ≥ 5.2, and of ≤ 4.67% salt and pH ≥ 5.6. No toxin was formed at salt concentrations of ≥ 5.56% or at pH ≤ 5.0. A survey of commercial caviar products showed that most of these had salt-pH combinations which would effectively inhibit C. botulinum at abusive temperatures during storage.
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/awers-inc-recalls-grained-salmon-caviar-95g-because-possible-health-risk
AWERS, Inc. Recalls Grained Salmon Caviar 95g Because of Possible Health Risk
Summary
Company Announcement Date: August 15, 2019
FDA Publish Date: August 15, 2019
Product Type:Food & Beverages
Reason for Announcement: Potential Clostridium Botulinum Contamination
Company Name:AWERS, Inc.
Brand Name:AWERS
Product Description: Grained Salmon Caviar